Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-01-09

FDA Approved: TERLIVAZ — Supplemental Application (Mallinckrodt Hospital Products Inc.)

View source ↗

Summary

FDA approved a supplemental application for Terlivaz (terlipressin) by Mallinckrodt Hospital Products Inc., resulting in changes to labeling and/or indication s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TERLIVAZ (terlipressin)

Snippet

SUPPL AP for TERLIVAZ (TERLIPRESSIN)